Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PKBO | Common Stock | Other | $0 | +6.44M | $0.00 | 6.42M | Nov 1, 2022 | Direct | F1 | |
transaction | PKBO | Common Stock | Other | $0 | +373K | +413957.78% | $0.00 | 373K | Nov 1, 2022 | See footnote | F1, F2 |
Id | Content |
---|---|
F1 | Received pursuant to the consummation of the transactions contemplated by that certain Business Combination Agreement between Ignyte Acquisition Corp. (the former name of the Issuer), a Delaware corporation, Peak Bio Co., Ltd., a corporation organized under the laws of the Republic of Korea, and Ignyte Korea Co., Ltd., a corporation organized under the laws of the Republic of Korea. |
F2 | The securities are held by Hannol Ventures LLC (the "LLC"). The Reporting Person is sole member of the LLC. |